Cannabis and COVID appeared in the mainstream headlines for the first time last month. This provides to be a small catalyst for both CBD and THC companies not only from a market perspective but more importantly from a cultural stigma perspective. We believe this news could help expedite federal rescheduling of CBD and hemp ingredients as well as push cannabis federal legalization forward. Couple that with one of the main vaccine manufacturers Pfizer buying Arena Pharmaceutical for $6.7 billion. The company is a clinical-stage pharmaceutical organization that specializes in cannabinoid-type therapeutics. The future for cannabinoids continues to become brighter.
Kellen Finney, Eighth Revolution
Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.
